↓ Skip to main content

Resistance to immune checkpoint inhibitors in advanced lung cancer: Clinical characteristics, potential prognostic factors and next strategy

Overview of attention for article published in Frontiers in immunology, January 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Resistance to immune checkpoint inhibitors in advanced lung cancer: Clinical characteristics, potential prognostic factors and next strategy
Published in
Frontiers in immunology, January 2023
DOI 10.3389/fimmu.2023.1089026
Pubmed ID
Authors

Jiebai Zhou, Xinyuan Lu, Haixing Zhu, Ning Ding, Yong Zhang, Xiaobo Xu, Lei Gao, Jian Zhou, Yuanlin Song, Jie Hu

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Professor 1 17%
Librarian 1 17%
Researcher 1 17%
Unknown 3 50%
Readers by discipline Count As %
Arts and Humanities 1 17%
Pharmacology, Toxicology and Pharmaceutical Science 1 17%
Unknown 4 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 January 2023.
All research outputs
#16,540,547
of 26,538,769 outputs
Outputs from Frontiers in immunology
#16,273
of 33,363 outputs
Outputs of similar age
#236,832
of 492,763 outputs
Outputs of similar age from Frontiers in immunology
#705
of 1,615 outputs
Altmetric has tracked 26,538,769 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 33,363 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 492,763 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 1,615 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.